Cargando…
Down-Regulating the High Level of 17-Beta-Hydroxysteroid Dehydrogenase 13 Plays a Therapeutic Role for Non-Alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide, and there is no specific drug to treat it. Recent results showed that 17-beta-hydroxysteroid dehydrogenase type 13 (HSD17B13) is associated with liver diseases, but these conclusions are controversial. Here...
Autores principales: | Wang, Meixi, Li, Jianrui, Li, Hu, Dong, Biao, Jiang, Jing, Liu, Nannan, Tan, Jiali, Wang, Xuekai, Lei, Lei, Li, Hongying, Sun, Han, Tang, Mei, Wang, Huiqiang, Yan, Haiyan, Li, Yuhuan, Jiang, Jiandong, Peng, Zonggen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146021/ https://www.ncbi.nlm.nih.gov/pubmed/35628360 http://dx.doi.org/10.3390/ijms23105544 |
Ejemplares similares
-
Synthesis and antiviral activity of a series of novel N-phenylbenzamide and N-phenylacetophenone compounds as anti-HCV and anti-EV71 agents
por: Jiang, Zhi, et al.
Publicado: (2015) -
A novel benzo-heterocyclic amine derivative N30 inhibits influenza virus replication by depression of Inosine-5’-Monophospate Dehydrogenase activity
por: Hu, Jin, et al.
Publicado: (2017) -
Effect of Eclipta prostrata on 11Beta-Hydroxysteroid Dehydrogenase in Rat Liver and Kidney
por: Xu, Chenshu, et al.
Publicado: (2014) -
Effect of Luteolin on 11Beta-Hydroxysteroid Dehydrogenase in Rat Liver and Kidney
por: Tang, Lei, et al.
Publicado: (2015) -
Hydroxysteroid 17-Beta Dehydrogenase 6 Is a Prognostic Biomarker and Correlates with Immune Infiltrates in Hepatocellular Carcinoma
por: Wu, Min, et al.
Publicado: (2021)